About: Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for autoimmune and inflammatory disorders in the United States. The company develops Tibulizumab, a humanized IgG4 single-chain variable fragment bispecific antibody engineered to bind and neutralize both IL-17A and BAFF within a single therapeutic molecule, which is in Phase 2 clinical trial development. It also develops Torudokimab (ZB-880), a fully human immunoglobulin G4 monoclonal antibody targeting interleukin-33 that has completed Phase 1 clinical studies; and Crebankitug (ZB-168), a fully human immunoglobulin G1 monoclonal antibody targeting interleukin-7 receptor alpha that has completed Phase 1 clinical studies. Zura Bio Limited was founded in 2022 and is headquartered in Henderson, Nevada.
Sector: Healthcare
Industry: Biotechnology
Latest price: $5.71 (-6.85%)
ZURANASDAQZura Bio Limited Class A Ordinary Shares
Zura Bio Limited Class A Ordinary Shares share price
ZURA price activity
Last Price
$5.710
Change (24hr)
-0.42 USD (-6.85%)
Volume
1.73M
Volume (4w avg)
-
Open
$6.04
Day Range
$5.63 - $6.05
Previous Close
$6.13
Last Trade
09 Sep, 8:05 pm GMT+0
Delayed
09 Sep, 8:05 pm GMT+0
ZURA price performance
Delayed
09 Sep, 8:05 pm GMT+0
ZURA Market Signals